GM(GM) Prnewswire·2025-02-23 16:30Core Insights - 10x Genomics announced new product innovations to enhance its leadership in single cell and spatial biology, aiming to support high-performance research at scale [1][2] - The company revealed a comprehensive product roadmap for its Visium and Xenium portfolios, focusing on advancements in spatial biology technology [1][3] Single Cell Innovations - The upcoming plate-based workflows for Chromium GEM-X Flex will allow researchers to process over 700 samples in a single run, recovering approximately 1 million cells from a single lane and 8 million cells per chip [3][5] - 10x Cloud Analysis for Large Studies will introduce batch analysis features, enabling hundreds or thousands of analyses to be run in parallel, enhancing data management capabilities [3][5] - Recent innovations aim to democratize access to single cell analysis by providing high performance at low costs, including GEM-X Flex Gene Expression at one cent per cell and GEM-X Universal Multiplex for approximately $600 per sample [5][6] Spatial Biology Advancements - The Visium HD product launched in 2024 significantly increased resolution and is now compatible with various tissue types, with plans for further enhancements [7][9] - The Xenium RNA+Protein Multiomics will allow simultaneous detection of RNA and proteins on the same slide, facilitating multiomic insights into cellular functions [7][9] - Upcoming Visium HD 3' assay will enhance whole transcriptome spatial profiling, improving performance and workflow for diverse applications [9][10] Company Positioning and Events - 10x Genomics continues to lead in spatial biology with a portfolio of technologies that provide high-resolution insights into tissue organization [6][11] - The company is hosting a workshop at the AGBT meeting to showcase its latest technologies and developments [2][8]